Latest news with #BungeGlobal
Yahoo
06-08-2025
- Business
- Yahoo
Glencore says long-term strategy may involve sale of Bunge stake
LONDON (Reuters) -Miner and trader Glencore said on Wednesday that its long-term strategy could involve the sale of its 16.4% stake in enlarged global agribusiness Bunge Global some time in the future. Glencore became the owner of the 16.4% stake after Bunge closed a long-delayed deal to merge with Glencore-backed grain handler Viterra in July, two years after announcing the $34 billion mega-deal. "The agriculture business is not necessarily consistent with our business model," Glencore CEO Gary Nagle told a media call on Wednesday after the company released its first-half financial results. "Having a 16.4% shareholding in Bunge is probably not something that would be for Glencore in the long term." He added that this did not mean Glencore would be in a rush to sell the stake, and if it ever decided to do that "we would do it in absolute collaboration and conjunction with Bunge, its board and its management". The merger with Viterra enhanced Bunge's grain exporting and oilseed processing businesses in the United States and expanded Bunge's export capacity and physical grain storage and handling footprint in major wheat suppliers Canada and Australia, according to analysts. Glencore's aim is to maximise the value of this investment, while the possible "exit of that at some stage in the future would be done very smartly and carefully to ensure that we preserve that value," the CEO added. Glencore said on July 2 that its 16.4% stake in enlarged Bunge had a market value of $2.6 billion at the deal close, and that those shares were viewed by the miner as a surplus capital.
Yahoo
05-08-2025
- Business
- Yahoo
International Flavors and Fragrances beats quarterly revenue, profit estimates
(Reuters) -International Flavors and Fragrances topped Wall Street estimates for second-quarter revenue and profit on Tuesday, driven by resilient demand, higher prices and a shift to better-margin businesses. The company has streamlined its portfolio as choppy demand in some food and beauty markets forced its customers to hold leaner inventories. On Tuesday, the company, which disposed of its pharma solutions business earlier this year, said it would sell its soy crush, concentrates, and lecithin unit to U.S. grain trader and processor Bunge Global. IFF did not disclose financial terms but said the operations generated about $240 million in revenue in 2024. The company posted net sales of $2.76 billion for the quarter ended June 30, beating estimates of $2.70 billion, according to data compiled by LSEG. Its adjusted profit of $1.15 per share also topped expectations of $1.12. Advance purchases by packaged food and beauty companies looking to beat higher prices due to tariffs also boosted sales at IFF in the reported quarter. "We remain on track to deliver our 2025 commitments we outlined earlier this year, even as the operating environment has become more challenging," said CEO Erik Fyrwald. IFF's shares were up nearly 5% in extended trading. They have fallen about 16% so far this year. The New York-headquartered company maintained its annual sales and adjusted core profit targets. The company also said it authorized a new share buyback program with a total value of $500 million. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-08-2025
- Business
- Yahoo
Bunge Global SA Just Beat EPS By 134%: Here's What Analysts Think Will Happen Next
Bunge Global SA (NYSE:BG) just released its latest quarterly results and things are looking bullish. It was overall a positive result, with revenues beating expectations by 2.8% to hit US$13b. Bunge Global also reported a statutory profit of US$2.61, which was an impressive 134% above what the analysts had forecast. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. After the latest results, the twin analysts covering Bunge Global are now predicting revenues of US$64.1b in 2025. If met, this would reflect a substantial 26% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to rise 6.4% to US$7.33. Before this earnings report, the analysts had been forecasting revenues of US$52.7b and earnings per share (EPS) of US$7.70 in 2025. Although revenue sentiment looks to be improving, the analysts have made a small dip in per-share earnings estimates, perhaps acknowledging the investment required to grow the business. View our latest analysis for Bunge Global The consensus price target was unchanged at US$88.00, suggesting the business is performing roughly in line with expectations, despite some adjustments to profit and revenue forecasts. One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. The analysts are definitely expecting Bunge Global's growth to accelerate, with the forecast 59% annualised growth to the end of 2025 ranking favourably alongside historical growth of 3.9% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 3.2% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Bunge Global is expected to grow much faster than its industry. The Bottom Line The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Bunge Global. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates. With that in mind, we wouldn't be too quick to come to a conclusion on Bunge Global. Long-term earnings power is much more important than next year's profits. We have analyst estimates for Bunge Global going out as far as 2026, and you can see them free on our platform here. You still need to take note of risks, for example - Bunge Global has 4 warning signs (and 2 which can't be ignored) we think you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
30-07-2025
- Business
- Yahoo
Here's What Key Metrics Tell Us About Bunge Global (BG) Q2 Earnings
For the quarter ended June 2025, Bunge Global (BG) reported revenue of $12.77 billion, down 3.6% over the same period last year. EPS came in at $1.31, compared to $1.73 in the year-ago quarter. The reported revenue represents a surprise of +12.45% over the Zacks Consensus Estimate of $11.36 billion. With the consensus EPS estimate being $1.19, the EPS surprise was +10.08%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Bunge Global performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Volumes - Agribusiness: 19,274.00 Kmt versus the two-analyst average estimate of 17,717.29 Kmt. Volumes - Milling products: 857.00 Kmt compared to the 992.85 Kmt average estimate based on two analysts. Volumes - Refined & Specialty Oils: 2,175.00 Kmt versus the two-analyst average estimate of 2,208.00 Kmt. Net sales to external customers- Agribusiness: $9.17 billion versus $7.75 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -5.1% change. Net sales to external customers- Milling products: $409 million versus $419.12 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +2% change. Net sales to external customers- Refined & Specialty Oils: $3.18 billion versus $3.18 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +1.8% change. Adjusted Segment EBIT- Agribusiness: $233 million versus $202.09 million estimated by two analysts on average. Adjusted Segment EBIT- Corporate and Other: $-83 million compared to the $-97.9 million average estimate based on two analysts. Adjusted Segment EBIT- Milling products: $27 million compared to the $25.74 million average estimate based on two analysts. Adjusted Segment EBIT- Refined & Specialty Oils: $116 million versus $138.56 million estimated by two analysts on average. View all Key Company Metrics for Bunge Global here>>> Shares of Bunge Global have returned -4.9% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bunge Global SA (BG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
San Francisco Chronicle
30-07-2025
- Business
- San Francisco Chronicle
Bunge Global: Q2 Earnings Snapshot
ST. LOUIS (AP) — ST. LOUIS (AP) — Bunge Global SA (BG) on Wednesday reported second-quarter net income of $354 million. The St. Louis-based company said it had net income of $2.61 per share. Earnings, adjusted for non-recurring gains, came to $1.31 per share. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.19 per share. The agribusiness and food company posted revenue of $12.77 billion in the period. Bunge Global expects full-year earnings to be $7.75 per share. Bunge Global shares have dropped nearly 2% since the beginning of the year. The stock has dropped 33% in the last 12 months. _____
